Extended Data Fig. 4: Plate maps and overview of compounds’ clinical phase status. | Nature Methods

Extended Data Fig. 4: Plate maps and overview of compounds’ clinical phase status.

From: Three million images and morphological profiles of cells treated with matched chemical and genetic perturbations

Extended Data Fig. 4: Plate maps and overview of compounds’ clinical phase status.

Maps in a-c show a) Compound plate, b) CRISPR plate and c) ORF plate. The control wells and the treatment (trt) wells are shown in different colors. Poscon are positive controls (additional details in the Methods section) and negcon is the negative control. d) Over a third of the compounds in the dataset have been launched for sale, whereas others have progressed to various stages of human clinical trials.

Back to article page